Indirect Comparisons of the Efficacy and Safety of Zanubrutinib versus Venetoclax plus Obinutuzumab in Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. [PDF]
Oncol TherMunir T +12 more
europepmc +1 more source
Aggressive Follicular Lymphoma of the Breast: An Unusual Suspect. [PDF]
CureusAli K +4 more
europepmc +1 more source
Cumulative review of cardiac failure with acalabrutinib in the treatment of chronic lymphocytic leukemia using data from clinical trials and postmarketing experience. [PDF]
HemasphereGhia P +5 more
europepmc +1 more source
Exceptional Response to Fixed Duration Obinutuzumab and Venetoclax in a Patient with Chronic Lymphocytic Leukemia: A Case Report. [PDF]
Case Rep OncolRosenberg M, Diefenbach C.
europepmc +1 more source
A novel radiosensitizer α-sulfoquinovosyl-acylpropanediol (SQAP) inhibits DNA repair pathways and sensitize cells to cancer chemotherapeutic agents. [PDF]
Sci RepMaeda J, Sunada S, Fukuhara T, Kato TA.
europepmc +1 more source
Diagnosis and treatment of chronic lymphocytic leukemia: 2025 recommendations of the Brazilian Group of Chronic Lymphocytic Leukemia of the Brazilian Association of Hematology and Hemotherapy (ABHH). [PDF]
Hematol Transfus Cell TherChiattone CS +22 more
europepmc +1 more source
Related searches: